NCT00702936

Telmisartan Versus Ramipril After Acute Coronary Syndrome

Telmisartan vs Ramipril for Reduction of Inflammation and Recruitment of Endothelial Progenitor Cells After Acute Coronary Syndrome

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Catholic University of the Sacred Heart · Academic / Other
• Sex: All
• Age: 40 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the antinflammatory and endothelial progenitor cell (EPC) mobilizing effect of Ramipril and Telmisartan in patients presenting with acute coronary syndrome

Conditions

• Acute Coronary Syndrome
• Myocardial Infarction
• Coronary Disease

Interventions

Type	Name	Description
DRUG	TELMISARTAN	80 mg daily
DRUG	RAMIPRIL	5 mg daily

Timeline

• Start date: 2007-11-01
• Primary completion: 2008-08-01
• Completion: 2008-11-01
• First posted: 2008-06-20
• Last updated: 2008-06-20

Locations

1 site across 1 country: Italy